Process for the preparation of l-cyano[(4-methoxyphenyl)methyl]-cyclohexanol of formula (I) of high purity, substantially free of impurities Comprising reaction of p-methoxy phenyl acetonitrile of formula (II)With cyclohexanone of formula (III)In an organic solvent selected from a lower aliphatic alcohol or an ether...

HERBAL EXTRACT COMPRISING A MIXTURE OF SAPONINS OBTAINED FROM SAPINDUS TRIFOLIATUS FOR ANTICONVULSANT ACTIVITY An extractr of the pericarp of the fruit of Sapindus trifoliatus comprising a mixture of triterpenoid saponins comprising from 0.001 to 1.0 (%w/v) of hederagenin. A pharmaceutical composition comprising...

N/A

N/A

The present invention relates to a novel, “green”, cost effective industrial process for the preparation of prostaglandin intermediate [D] wherein P is protecting group and R is residual side chain, using reverse micellar solution as well as water in oil micro emulsion.

The present invention relates to a novel process for synthesis of testosterone (1) from 4-androstene-3,17-dione (2) in micellar aggregates.

The present invention relates to a process for the preparation of lopinavir : oxalic acid co-crystal comprising crystallization of lopinavir and oxalic acid in a suitable solvent.

Extended release pharmaceutical composition of Venlafaxine hydrochloride comprising a pharmaceutically acceptable capsule containing minitablets. The minitablets comprise from about 20% to about 70% by weight effective amount of Venlafaxine hydrochloride, polyvinyl acetate, one or more pharmaceutically acceptable ex...

A chewable tablet comprising Cefixime having a mean particle size between 20μ and 120μ wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle ...

A process for preparation of 4-hydroxy-pyran-2-one derivative of formula (I), and wherein R¹ and R² are methyl and R³ is hydrogen or methyl, comprising the steps of, heating a compound of formula (II), wherein R is as defined before, and R4 is hydrogen, NH4+ or an alkali metal, 29 in a solvent mixture consisting of ...

The present invention provides a process of preparation of Atovaquone more particularly the present invention relates to a novel cost effective and industrial feasible process, without separation of any diastereoisomers or geometric isomers of intermediates obtained during the preparation of Atovaquone ...

A process for producing 4-bromo-2-oxyimino butyric acid, predominantly as the (Z)-isomer of formula (I), wherein R is hydrogen ; a linear or branched C1-4 alkyl group; a linear or branched C1-4 alkyl group substituted by a carboxylic acid or an aryl group; a substituted or unsubstituted cyclic al...

A pharmaceutical composition comprising a herbal extract, comprising a mixture of saponins prepared from the pericarp of Sapindus trifoliatus. , with binding affinities for the receptor sites viz. GABA-A agonist site, Glutamate-AMPA site, Glutamate-Kainate site, Glutamate-NMDA agonistic site. Glutamate-NMDA ...